<p>Objectives:</p>
<p>1. Describe the unmet medical needs in locally advanced head and neck squamous cell carcinoma (LA HNSCC),</p>
<p>2. Explain the scientific and clinical rationale for the use of immuno-oncology therapies in the neoadjuvant and adjuvant settings for resectable LA HNSCC,</p>
<p>3. Review and interpret the most recent clinical data in resectable LA HNSCC,</p>
<p>4. Apply emerging evidence and evolving standards to optimize patient care in the new era of resectable LA HNSCC, with a focus on individualized treatment planning, multidisciplinary collaboration, and improving patient outcomes</p>
